Clinical Trial Update: Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating peri-operative immunotherapy with chemotherapy in operable gastric and oesophageal adenocarcinoma. Status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Oesophageal Adenocarcinoma

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Gastric Adenocarcinoma, Oesophageal Adenocarcinoma | Phase 2 | Status: UNKNOWN